Zobrazeno 1 - 10
of 143
pro vyhledávání: '"G. R. Tabeeva"'
Autor:
G. R. Tabeeva
Publikováno v:
Сеченовский вестник, Vol 0, Iss 1, Pp 40-46 (2022)
This article discusses the problem of studying fibromyalgia at the present stage, examines the application of the current criteria for the diagnosis and treatment of this disease.
Externí odkaz:
https://doaj.org/article/643719140c3c45e9a8191415dc146888
Publikováno v:
Сеченовский вестник, Vol 0, Iss 3, Pp 25-30 (2022)
Primary headache associated with sexual activity (PHASA) is a form of primary headaches, precipitated by sexual activity, in the absence of any intracranial disorder. Two types of PHASA are discerned: preorgasmic and orgasmic. A case of 44 years old
Externí odkaz:
https://doaj.org/article/504d461444d84e47a34ec195d5c16524
Autor:
A. V. Sergeev, G. R. Tabeeva, E. G. Filatova, A. V. Amelin, L. R. Akhmadeeva, E. R. Lebedeva, V. V. Osipova, Yu. E. Azimova, N. V. Latysheva, O. B. Doronina, K. V. Skorobogatykh
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 14, Iss 5, Pp 109-116 (2022)
This consensus reviewed the main current issues of clinical application and integration into everyday practice of a new targeted preventive therapy for migraine using monoclonal antibodies (mAbs) to the calcitonin gene related peptide (CGRP) ligand o
Externí odkaz:
https://doaj.org/article/aed33d42913549629b5ada854bc02631
Autor:
G. R. Tabeeva, V. V. Osipova, E. G. Filatova, Yu. E. Azimova, A. V. Amelin, A. R. Artyomenko, Yu. D. Vorobyeva, E. V. Ekusheva, M. I. Koreshkina, E. R. Lebedeva, N. V. Latysheva, M. V. Naprienko, A. V. Sergeev, K. V. Skorobogatykh, V. A. Golovacheva, A. P. Rachin, V. A. Parfenov
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 14, Iss 1, Pp 4-13 (2022)
The Russian experts’ guidelines on evaluation and treatment of medication-overuse headache are based on evidence-based medicine, the latest revision of the International Classification of Headache Disorders. Basic information about epidemiology, ri
Externí odkaz:
https://doaj.org/article/5a6041acab8b43c99e71cc3e4c2deb08
Autor:
G. R. Tabeeva, Z. Katsarava, A. V. Amelin, A. V. Sergeev, K. V. Skorobogatykh, I. V. Efimenko, V. F. Khoroshevskiy
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 13, Iss 6, Pp 73-84 (2021)
Migraine is the second leading cause of maladjustment, and the burden of migraine is determined by its impact on work ability, social activity and family relationships.Objective: to identify the patterns of behavior of Russian patients with migraine,
Externí odkaz:
https://doaj.org/article/f6b1ef9e89ac4db2933566b030fcb6b2
Publikováno v:
Медицинский совет, Vol 0, Iss 12, Pp 426-432 (2021)
Introduction. Menstrual migraine attacks are considered more intense, prolonged, and resistant to treatment than non-menstrual ones. Currently, effect of preventive therapy on the course of menstrual-associated migraine has not been well studied; the
Externí odkaz:
https://doaj.org/article/a9adf67fbef64dd484a67dbfb04aa39d
Autor:
E. A. Kiryanova, G. R. Tabeeva
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 13, Iss 4, Pp 12-17 (2021)
Migraine is the first most frequent cause of disability among women of reproductive age globally, and up to 60% of patients note the association of headache attacks with menstruation.Objective: to determine the features of menstrual cycle and gynecol
Externí odkaz:
https://doaj.org/article/0a02b538bd7d4137923e42170e7a7d2a
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 13, Iss 4, Pp 81-87 (2021)
Patient needs, drug intake patterns, and adherence to therapy are significant challenges in the management of migraine patients.Objective: to identify drug treatment needs, drug use patterns and adherence factors in migraine patients.Patients and met
Externí odkaz:
https://doaj.org/article/c95d5a7f172048e590ea1fd78f1932dc
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 13, Iss 3, Pp 27-33 (2021)
Patients with primary headaches are prone to frequent uncontrolled use of analgesics, leading to medication-overuse headache (MOH). One of the most accessible and effective strategies for its prevention is informing patients about the potential dange
Externí odkaz:
https://doaj.org/article/b9f030ebe3af4969b31901a009bc85e4
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 13, Iss 2, Pp 123-129 (2021)
Cognitive impairment (CI) can be neurological symptoms or complications of coronavirus disease 2019 (COVID-19). Among the pathogenetic mechanisms, the neurotropicity of the SARS- CoV-2 virus, endothelial dysfunction, coagulopathy, thrombus formation,
Externí odkaz:
https://doaj.org/article/12b44c586791463881e11b8165d7f5be